Balance Sheet
Cash Flow Statement
Capital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in InventoryChange in ReceivablesDepreciation & Amortization (CF)Depreciation and DepletionFree Cash FlowGains from Investment SecuritiesGains from Sales and DivestituresNet Cash FlowNet IncomeOther Working Capital ChangesOther financing activitiesShare-based CompensationShares IssuedShort-Term Debt issuancesShort-Term Debt repayments
Daily Values
Growth Metrics
Income Statement
Others
Ratios

bioAffinity Technologies (BIAF) Other Working Capital Changes (2022 - 2025)

bioAffinity Technologies (BIAF) has disclosed Other Working Capital Changes for 4 consecutive years, with $59729.0 as the latest value for Q4 2025.

  • Quarterly Other Working Capital Changes changed N/A to $59729.0 in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $90060.0 through Dec 2025, up 1140.67% year-over-year, with the annual reading at $90060.0 for FY2025, 1140.67% up from the prior year.
  • Other Working Capital Changes for Q4 2025 was $59729.0 at bioAffinity Technologies, down from $60037.0 in the prior quarter.
  • The five-year high for Other Working Capital Changes was $530481.0 in Q3 2022, with the low at -$252652.0 in Q4 2023.
  • Average Other Working Capital Changes over 4 years is $23983.8, with a median of -$4500.0 recorded in 2023.
  • The sharpest move saw Other Working Capital Changes tumbled 2580.94% in 2023, then soared 3568.34% in 2025.
  • Over 4 years, Other Working Capital Changes stood at -$9424.0 in 2022, then crashed by 2580.94% to -$252652.0 in 2023, then surged by 99.31% to -$1731.0 in 2024, then surged by 3550.55% to $59729.0 in 2025.
  • According to Business Quant data, Other Working Capital Changes over the past three periods came in at $59729.0, $60037.0, and -$23260.0 for Q4 2025, Q3 2025, and Q2 2025 respectively.